Global Bioinformatics Platforms Market
The rapid development of next-generation sequencing technology has increased the amount of microbial genomes available. This in turn has led to an increasing demand for bioinformatics platforms that support the comparison of closely related genomes.
The goal of the bioinformatics platform is to provide highly-specialized bioinformatics support in the areas of genomics, proteomics, epigenomics, transcriptomics, systems biology, and high-throughput screen deconvolution. Several bioinformatics tools have been developed such as EDGAR, Roary, MBGD, IMG/M, and MicrobesOnline.
𝐆𝐞𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐨𝐟 𝐎𝐮𝐭 𝐋𝐚𝐭𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: @ https://www.coherentmarketinsights.com/insight/request-sample/2664
Increasing focus on drug development or drug discovery is expected to boost the growth of the global bioinformatics platforms market over the forecast period. Healthcare organizations, non-profit organizations, and pharmaceutical companies are increasingly utilizing their capabilities and funds for drug development and drug discovery. For instance, government initiatives, such as Horizon 2020 and Innovate UK offer research organizations and businesses with grants to help them drive their scientific research. Innovate UK is the UK’s national innovation agency. The program supported two companies, C4X Discovery and Adorial Pharma Limited, for the development of a novel system of drug discovery.
Moreover, market players are adopting various strategies, such as product launch, merger and acquisition, to strengthen their market presence. For instance, in April 2014, Dassault Systèmes announced the completion of its acquisition of Accelrys, Inc. Furthermore, Dassault Systèmes announced the introduction of its new brand, BIOVIA, to provide scientific enterprise software for chemical, materials, and bioscience research for biotechnology, pharmaceutical, consumer packaged goods, energy, aerospace, and chemical industries.
𝐑𝐞𝐜𝐞𝐢𝐯𝐞 𝐚 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/2664
By Platform Type:
- Sequence Analysis Platforms
- Sequence Alignment Platforms
- Sequence Manipulation Platforms
- Structural & Functional Analysis Platforms
- Drug Development
- Molecular Genomics
- Personalized Medicine
- Gene Therapy
- Protein Function Analysis
By End User:
- Academic and Research Organizations
- Contract Research Organizations
- Pharmaceutical and Biotechnology Organizations
- North America
- Latin America
- Asia Pacific
- Middle East
North America and Europe is expected to witness robust growth in the global bioinformatics platforms market due to the increasing research and development, increasing adoption of new and advanced technology, increasing mergers and acquisitions of key players in these regions. For instance, in October 2013, Qiagen announced the acquisition of CLC Bio, a bioinformatics software company based in Denmark. CLC Bio focuses on the development and marketing of software for the analysis of genomic data from sequencing platforms and conventional Sanger sequencing tools.
Major players active in the global bioinformatics platforms market are Illumina, Inc., Agilent Technologies Inc., ID Business Solutions, Ltd., QIAGEN, Dassault Systemes, Affymetrix, Inc., and GenoLogics Life Sciences Software, Inc., among others.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/2664
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027